Thursday Session Schedule
Welcome to BCT ASM
The theme for Session 1 is Supportive Care.
Session Chairs Opening: Dr Nicholas Zdenkowski and Ms Laura McCambridge.
Bruce Mann
Burn Out and Self-Care for the Clinician
Lesley Fallowfield
Fear of Recurrence
Ben Smith
Sexual Health of Breast Cancer Patients
Belinda Yeo
Virginia Baird
Morning Tea Break
Abstract Poster Viewing with Authors.
Session Chairs: Ms Leslie Gilham and Ms Jenny Gilchrist.
Cardiac Care Post-Breast Cancer: Monitoring and Management Strategies
Thomas Marwick
Abstract Presentation
Addressing the Fear of Recurrence with Project Shirley: Identifying Psychosocial Needs in Australian Patients with HR+ HER2- Early Breast Cancer.
Jenny Gilchrist
EPROMS: BCT Patient Reported Outcomes
Julia Matheson
Patient Involvement in Study Design
Stuart McIntosh
Abstract Presentation
AFT-38 PATINA: A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy after Induction Treatment for Hormone Receptor-Positive (HR+)/HER2-Positive Metastatic Breast Cancer.
Elgene Lim
Session Close
Daiichi-Sankyo | AstraZeneca will hold a Lunch Symposium during the break on Thursday 24 July. Click here to find out more.
Introduction to Session
The theme for Session 2 is Translational Research.
Session Chairs: Associate Professor Amy McCart Reed and Professor Sunil Lakhani.
How do we Facilitate the Path to Translation? Basic Science from the Scientist POV
Christine Chaffer
From Bench to Bedside, 4CASTing a New Treatment for TNBC
Rachel Dear
Advancing Breast Cancer Therapeutics in Australia and New Zealand
Rachel Galimidi
Targeting CDKs in Breast Cancer: Novel Agents in Clinical Development
Shom Goel
Afternoon Tea Break
Welcome Back to Session
Session Chairs: Associate Professor Christine Chaffer and Professor Geoff Lindeman.
Robert Sutherland Award Presentation by Cheryl Sutherland
Circulating Tumour DNA in Breast Cancer: Concepts, Challenges and Future Opportunities
Sarah-Jane Dawson
Abstract Presentation
Primary efficacy results of tremelimumab and durvalumab in combination with trastuzumab in trastuzumab-resistant advanced HER2-positive breast cancer: BCT1703 DIAmOND.
Nick Zdenkowski
Assessing Toxicity in Clinical Trials: Is it Fit for Purpose?
Sunil Lakhani
Abstract Presentation
The WinPro Trial: A Window of Opportunity Study of Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Hormone Receptor-Positive Breast Cancer.
Elgene Lim
PALLAS Trial Adverse Event Analysis: CTCAE vs PRO
Nick Zdenkowski
Session Close